Gary Zweiger, PhD is a geneticist and Director of Business Development and Strategic Planningat Agilent Technologies, a leading producer of DNA microarrays (gene chips) and other biomedical tools. Prior to joining Agilent, he was Senior Strategic Advisor at Incyte Genomics, Inc., a founding company in the genomics industry. He has also worked as a consultant to venture capitalists, investment bankers, and other early backers of the emerging genomics industry, and has taught classes in human biology and biotechnology at several colleges. While at Incyte, Dr. Zweiger studied thousands of genes by using enormous biological databases and designed several powerful microarrays to help further his research into the molecular changes that accompany prostate, breast, colon, and pediatric cancers.